EY Life Sciences Extended Lunch Session

Gain practical insights on transitioning to the new requirements of the new Revenue Recognition Standard

  • Share

Please join us for this complimentary roundtable discussion and networking session where we will present and discuss the impact the new revenue recognition standard (IFRS 15) will have specifically for life sciences companies. The discussion will be entirely focused on life sciences specific issues, examples, and implementation questions.

EY Speakers:

  • Jürg Zürcher, Partner, Biotech/Medtech Leader Germany Switzerland Austria (GSA)
  • Frederik Schmachtenberg, PhD, Senior Manager, Life Sciences Financial Accounting Advisory Services

 Topics will include:

  • Applying the new revenue recognition standard to an exemplary collaboration agreement
  • Highlighting specific considerations in connection with new product launches
  • Practical considerations on transitioning to the new requirements, incl. impacts on processes and controls
  • New and additional documentation requirements in connection with the new standard

    Agenda:

    • 11:30 am –12:00 pm | Registration
    • 12:00 pm –1:00 pm | EY presentation and lunch
    • 1:00 pm –1:30 pm | Discussion and Q&A